These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 23654226

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Design of on-target FAAH inhibitors.
    Deutsch DG.
    Chem Biol; 2005 Nov; 12(11):1157-8. PubMed ID: 16298293
    [Abstract] [Full Text] [Related]

  • 23. Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH).
    Min X, Thibault ST, Porter AC, Gustin DJ, Carlson TJ, Xu H, Lindstrom M, Xu G, Uyeda C, Ma Z, Li Y, Kayser F, Walker NP, Wang Z.
    Proc Natl Acad Sci U S A; 2011 May 03; 108(18):7379-84. PubMed ID: 21502526
    [Abstract] [Full Text] [Related]

  • 24. [11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography.
    Wilson AA, Garcia A, Parkes J, Houle S, Tong J, Vasdev N.
    Nucl Med Biol; 2011 Feb 03; 38(2):247-53. PubMed ID: 21315280
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Binding and inactivation mechanism of a humanized fatty acid amide hydrolase by alpha-ketoheterocycle inhibitors revealed from cocrystal structures.
    Mileni M, Garfunkle J, DeMartino JK, Cravatt BF, Boger DL, Stevens RC.
    J Am Chem Soc; 2009 Aug 05; 131(30):10497-506. PubMed ID: 19722626
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Tandem mass spectrometric data-FAAH inhibitory activity relationships of some carbamic acid O-aryl esters.
    Basso E, Duranti A, Mor M, Piomelli D, Tontini A, Tarzia G, Traldi P.
    J Mass Spectrom; 2004 Dec 05; 39(12):1450-5. PubMed ID: 15578755
    [Abstract] [Full Text] [Related]

  • 35. ω-Imidazolyl- and ω-Tetrazolylalkylcarbamates as Inhibitors of Fatty Acid Amide Hydrolase: Biological Activity and in vitro Metabolic Stability.
    Terwege T, Hanekamp W, Garzinsky D, König S, Koch O, Lehr M.
    ChemMedChem; 2016 Feb 17; 11(4):429-43. PubMed ID: 26732805
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. O-(triazolyl)methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors.
    Colombano G, Albani C, Ottonello G, Ribeiro A, Scarpelli R, Tarozzo G, Daglian J, Jung KM, Piomelli D, Bandiera T.
    ChemMedChem; 2015 Feb 17; 10(2):380-95. PubMed ID: 25338703
    [Abstract] [Full Text] [Related]

  • 39. Physical Nature of Fatty Acid Amide Hydrolase Interactions with Its Inhibitors: Testing a Simple Nonempirical Scoring Model.
    Giedroyć-Piasecka W, Dyguda-Kazimierowicz E, Beker W, Mor M, Lodola A, Sokalski WA.
    J Phys Chem B; 2014 Dec 26; 118(51):14727-36. PubMed ID: 25420234
    [Abstract] [Full Text] [Related]

  • 40. Elucidation of hydrolysis mechanisms for fatty acid amide hydrolase and its Lys142Ala variant via QM/MM simulations.
    Tubert-Brohman I, Acevedo O, Jorgensen WL.
    J Am Chem Soc; 2006 Dec 27; 128(51):16904-13. PubMed ID: 17177441
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.